Exploring the Landscape of PARP Inhibitor Combinations in Metastatic Prostate Cancer: Trials, Efficacy, and Future Directions

Exploring the Landscape of PARP Inhibitor Combinations in Metastatic Prostate Cancer: Trials, Efficacy, and Future Directions In recent years, the landscape of metastatic prostate cancer treatment has been significantly transformed by the advent of PARP inhibitors. These drugs, which target the DNA repair pathways in cancer cells, have shown promise when used in combination with […]